ALF’s Official Charity Marathon Team Runs in 130th Annual Boston Marathon to Fight Liver Disease
BOSTON, April 17, 2026 /PRNewswire/ -- American Liver Foundation (ALF) is proud to once again be a member of the...
BOSTON, April 17, 2026 /PRNewswire/ -- American Liver Foundation (ALF) is proud to once again be a member of the...
GUANGZHOU, China , April 17, 2026 /PRNewswire/ -- From March 28 to 30, 2026, the 4th International Conference on Single-Cell and...
Presenting initial TRACERx MRD data showcasing low single-digit parts-per-million sensitivity for ctDNA detection with ppmSeq Additional collaborations also demonstrate ultra-sensitive...
MPA combines Medicare enrollment, over 17 life insurance products, AI-driven lead generation, 50-state compliance monitoring, commission tracking, and post-sale retention...
Elite Ultra-Marathoner targets her second World Record in two months following historicUltra Jackpot 100 Win ESTERO, FL / ACCESS Newswire...
Today through April 20, Zide Door is offering special 4/20 promotions for church members in honor of the deep spiritual...
Global Widget, LLC, a leading U.S.-based contract manufacturer specializing in gummy supplements, is celebrating its 10-year anniversary after a decade...
In a 12‑week comparative study, Omada GLP‑1 Care Track members, on average, lost more weight and saw greater improvements in...
SOUTH SAN FRANCISCO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage...
KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company...
INBS implements enhanced security architecture to protect test integrity and donor data, strengthening upcoming FDA 510(k) submissionNEW YORK, April 17,...
EMJ Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between...
New After-School and Hybrid Home ABA programs for children under 6WOBURN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Families of...
Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for...
– Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in skin...
WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file...
Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinomaPHILADELPHIA, April 17,...
WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,...
MELBOURNE, Australia and SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the...
Strong global consensus on measurement and role of ammonia in Hepatic Encephalopathy (HE)Phase 2a results of YAQ007 (oral OPA) show...